Jamjoom Pharma’s profit near SAR 171m in H1-23; dividends announced

Jamjoom Pharma’s profit near SAR 171m in H1-23; dividends announced

Riyadh – Mubasher: The net profits after Zakat and tax of Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) hiked by 81.59% to SAR 170.70 million in the first half (H1) of 2023, versus SAR 94 million in H1-22. Revenues stood at SAR 600.30 …